Stephan Rimpler,Sabine Grapatin,Cliff Krein,Markus Thelen
申请号：
US10344884
公开号：
US08604076B2
申请日:
2001.08.21
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Pharmaceutical compositions are provided for administration of rotigotine in depot form. Pharmaceutical compositions of the invention can provide therapeutically significant plasma levels of rotigotine over a period of at least 24 hours after administration to a patient. Preferred pharmaceutical compositions of the invention include oily suspensions that contain rotigotine in solid form as well as anhydrous pharmaceutical compositions that comprise rotigotine.
